Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/9874784

Proc. Natl. Acad. Sci. U.S.A. 1999 Jan 5 96 1 133-8

Download in:

View as

Triples

General Info

PMID
9874784